Location History:
- Milton, MA (US) (2000)
- Westborough, MA (US) (2010)
Company Filing History:
Years Active: 2000-2010
Title: The Innovative Contributions of Jane B Lian
Introduction
Jane B Lian is a prominent inventor based in Westborough, MA (US). She has made significant contributions to the field of biological research, particularly in the analysis of nuclear architecture and its implications for biological control. With a total of 2 patents, her work has garnered attention for its innovative approaches to understanding cellular functions.
Latest Patents
One of Jane B Lian's latest patents is titled "Quantitative assessment of biological function based on the temporal and spatial organization of subnuclear domains." This invention provides a method for analyzing the punctate distribution of supramolecular complexes that are compartmentalized in nuclear microenvironments. The method allows for quantitative analysis of the assembly of regulatory machinery within the context of nuclear architecture, establishing a mechanistic link with biological control. Another notable patent is "Isolated nuclear matrix targeting peptide," which discloses nuclear matrix targeting peptides (NMTPs) capable of delivering various therapeutic and diagnostic agents to the nuclear matrix of a cell.
Career Highlights
Throughout her career, Jane has worked with esteemed institutions such as the University of Massachusetts and St. Jude Children's Research Hospital. Her research has focused on the intricate relationships between cellular components and their functions, contributing to advancements in the field of molecular biology.
Collaborations
Jane has collaborated with notable colleagues, including Gary S Stein and Andre J Van Wijnen. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Jane B Lian's innovative work in the field of biological research exemplifies the importance of understanding cellular mechanisms. Her patents reflect a commitment to advancing scientific knowledge and improving therapeutic approaches.